Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cells of the Adaptive Immune Response

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HISTAI: a valuable dataset with a valuable lesson.

The journal of pathology. Clinical research·2026

Same author

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial).

Hepatology (Baltimore, Md.)·2026

Same author

From pathogenesis to treatment: the role of autophagic cell death in GONFH and its potential mitigation by naringenin.

Theranostics·2026

Same author

Corrigendum to "Treatment of hemophilic arthropathy by immunomodulatory extracellular vesicle delivered by liposome hybrid nanoparticles" [Bioact. Mater. 40 (2024) 47-63].

Bioactive materials·2025

Same author

Myristic Acid Remodels Sphingolipid Metabolism via Dual Pathways: Canonical d18-Sphingolipid Regulation and Non-Canonical d16-Sphingolipid Synthesis.

Nutrients·2025

Same author

Fufang Duzhong Jiangu granule (FFDZ) ameliorates osteoarthritis development through maintaining subchondral bone homeostasis.

Frontiers in cell and developmental biology·2025

Search research articles

Related Experiment Video

Updated: Jul 8, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.

Nikolai Przybylski¹, Qinghe Zeng¹, Xiao Huang¹

¹School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, PA, United States.

Advances in Pharmacology (San Diego, Calif.)

|July 6, 2026

Summary

T-cell therapy manufacturing is a biological process that programs cell fate and function. Optimizing manufacturing steps is key to enhancing T-cell therapy efficacy, durability, and scalability for diverse applications.

Keywords:

Cell quality Cell quantity Ex vivo stimulation T-cell manufacturing T-cell phenotype

More Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

Related Experiment Videos

Last Updated: Jul 8, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

Area of Science:

Cellular therapy
Bioprocessing
Immunotherapy

Background:

T-cell therapies are revolutionizing cancer treatment and expanding to other diseases.
Unlike traditional drugs, T-cell therapies are living therapeutics whose manufacturing critically impacts their function.
The ex vivo manufacturing process is a key biological determinant of T-cell therapy outcomes.

Purpose of the Study:

To present a framework conceptualizing manufacturing as biological programming for T-cell therapies.
To review how manufacturing steps influence T-cell quantity and quality.
To highlight strategies for next-generation T-cell manufacturing.

Main Methods:

Review of T-cell processing steps: isolation, selection, activation, transduction, expansion, and formulation.
Analysis of extracellular cues (e.g., activation materials, cytokines, nutrients, gene delivery) influencing T-cell phenotype, fitness, and durability.
Emphasis on transcriptional, epigenetic, and metabolic programming during manufacturing.

Main Results:

Manufacturing decisions significantly impact T-cell phenotype, fitness, and functional durability.
Each processing step influences the balance between cell quantity and quality, crucial for clinical efficacy.
Extracellular cues during manufacturing shape cellular programs linked to therapeutic outcomes.

Conclusions:

Manufacturing should be viewed as a controllable biological intervention, not just logistics.
Optimizing manufacturing can lead to more potent, durable, and scalable T-cell products.
Understanding manufacturing's biological programming is essential for advancing T-cell therapies.